Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangioma × Therapeutics × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 35 Neoplasms 29 Fatigue 23 Depression 22 Prostatic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 14 Multiple Myeloma 13 Colorectal Neoplasms 13 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Lung Neoplasms 11 Leukemia, Myeloid, Acute 11 Hodgkin Disease 11 Leukemia, Myeloid, Chronic-Phase 10 Blast Crisis 10 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Accelerated Phase 9 Leukemia, Hairy Cell 9 Anxiety Disorders 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8 Carcinoma, Ovarian Epithelial 8 Vomiting 7 Sezary Syndrome 7

Interventions

Propranolol 9 Timolol 5 Prednisolone 5 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Prednisone 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866827 2019-01-11

Airway Vascular Lesions

University of Arkansas

Hemangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡